Trial intelligence / Profile preview

Alprazolam and Simulated Driving Performance

NCT03297944Phase 4Completed

Start
Sep 2017
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alprazolam in anxiety disorder. Started Sep 2017; status: completed.

02

Drugs

alprazolam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on NCT03297944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03297944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call